These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21795339)

  • 21. In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
    Binford SL; Weady PT; Maldonado F; Brothers MA; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4366-73. PubMed ID: 17908951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on enterovirus 71 infection and interferon type I response.
    Rasti M; Khanbabaei H; Teimoori A
    Rev Med Virol; 2019 Jan; 29(1):e2016. PubMed ID: 30378208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
    Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
    Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
    Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
    Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Enterovirus 71 replication by 7-hydroxyflavone and diisopropyl-flavon7-yl Phosphate.
    Wang J; Su H; Zhang T; Du J; Cui S; Yang F; Jin Q
    PLoS One; 2014; 9(3):e92565. PubMed ID: 24664133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyanohydrin as an Anchoring Group for Potent and Selective Inhibitors of Enterovirus 71 3C Protease.
    Zhai Y; Zhao X; Cui Z; Wang M; Wang Y; Li L; Sun Q; Yang X; Zeng D; Liu Y; Sun Y; Lou Z; Shang L; Yin Z
    J Med Chem; 2015 Dec; 58(23):9414-20. PubMed ID: 26571192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragment-wise design of inhibitors to 3C proteinase from enterovirus 71.
    Wu C; Zhang L; Li P; Cai Q; Peng X; Yin K; Chen X; Ren H; Zhong S; Weng Y; Guan Y; Chen S; Wu J; Li J; Lin T
    Biochim Biophys Acta; 2016 Jun; 1860(6):1299-307. PubMed ID: 26987809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
    Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
    Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
    Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
    J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
    Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
    J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity-Based Protein Profiling Identifies ATG4B as a Key Host Factor for Enterovirus 71 Proliferation.
    Sun Y; Zheng Q; Wang Y; Pang Z; Liu J; Yin Z; Lou Z
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31554687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
    Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
    Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
    Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
    Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
    Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16.
    Kelly JT; De Colibus L; Elliott L; Fry EE; Stuart DI; Rowlands DJ; Stonehouse NJ
    Antiviral Res; 2015 Dec; 124():77-82. PubMed ID: 26522770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells
    Kitano M; Hosmillo M; Emmott E; Lu J; Goodfellow I
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
    Anand K; Ziebuhr J; Wadhwani P; Mesters JR; Hilgenfeld R
    Science; 2003 Jun; 300(5626):1763-7. PubMed ID: 12746549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes.
    Matthews DA; Dragovich PS; Webber SE; Fuhrman SA; Patick AK; Zalman LS; Hendrickson TF; Love RA; Prins TJ; Marakovits JT; Zhou R; Tikhe J; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; Brothers MA; DeLisle DM; Worland ST
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11000-7. PubMed ID: 10500114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China.
    Wu Y; Lou Z; Miao Y; Yu Y; Dong H; Peng W; Bartlam M; Li X; Rao Z
    Protein Cell; 2010 May; 1(5):491-500. PubMed ID: 21203964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.